Non-small Cell Squamous Lung Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-08-12
Clinical Trial Update: Sintilimab, Anlotinib Hydrochloride and Platinum-Containing Dual-Agent Chemotherapy in NSCLC [Phase 2]
Phase 2 trial evaluating sintilimab, anlotinib hydrochloride, and platinum-containing chemotherapy in metastatic/recurrent non-small cell lu…